Vikram Sengupta, MD
Strategic Vice President of Clinical Affairs

Dr. Sengupta attended Cornell University, majoring in neuroscience, before moving on to the Yale School of Medicine, where he earned his MD. He is fellowship-trained in interventional pain management and board-certified in internal medicine. His clinical areas of focus are regenerative medicine and neuromodulation.

Dr. Sengupta is an experienced specialist in site-of-care optimization and the implementation of medical services. He has conducted groundbreaking, first-in-human clinical research using stem cell-derived biologics to treat COVID-19-related ARDS and cytokine storm, as well as the use of implantable neurostimulation devices for the treatment of pain. He is currently the primary investigator on several national multi-center clinical trials.

He has served on the faculty at Harvard and NYU.